Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Pharmaceuticals Other
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MYOK | MyoKardia, Inc. | 0.09% | 223.53 | 1.8% | $529.51m | |
| HZNP | Horizon Therapeutics Plc | -3.59% | 74.93 | 5.8% | $156.10m | |
| VRX | Valeant Pharmaceuticals International, Inc. | -2.08% | 16.50 | 14.1% | $97.09m | |
| JAZZ | Jazz Pharmaceuticals Plc | -1.05% | 144.10 | 2.4% | $73.67m | |
| CTLT | Catalent, Inc. | -1.80% | 87.78 | 2.1% | $69.26m | |
| UTHR | United Therapeutics Corp. | 3.06% | 134.23 | 14.1% | $68.71m | |
| BHC | Bausch Health Cos., Inc. | -2.08% | 16.50 | 0.0% | $59.77m | |
| SAGE | SAGE Therapeutics, Inc. | -0.72% | 73.38 | 8.6% | $45.85m | |
| ICLR | ICON plc | -1.62% | 180.30 | 4.2% | $42.06m | |
| ARGX | argenx SE | -2.46% | 248.13 | 0.0% | $35.01m | |
| PRGO | Perrigo Co. Plc | 3.08% | 43.84 | 6.8% | $32.61m | |
| ENDP | Endo International Plc | -3.38% | 4.57 | 8.7% | $30.02m | |
| GWPH | GW Pharmaceuticals Plc | 0.76% | 90.01 | 6.2% | $28.78m | |
| AMRN | Amarin Corp. Plc | -1.22% | 4.86 | 1.5% | $26.85m | |
| ICPT | Intercept Pharmaceuticals, Inc. | -3.97% | 27.79 | 16.8% | $23.24m |
Company Profile
SAGE Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of novel medicines to treat life-altering central nervous system. Its programs include brexanolone, which is an acute interventional treatment for postpartum depression; and SAGE-217, an oral therapy for treatment of various CNS disorders. The company was founded by Steven Marc Paul and Douglas Covey in April 2010 and is headquartered in Cambridge, MA.